Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Paired tVNS With ERP in OCD

NCT: NCT05580614 · RECRUITING

NCT IDNCT05580614
StatusRECRUITING
Start Date2022-06-27
Completion2026-08-31
SponsorUniversity of Florida (OTHER)
First posted
Last updated

Brief Summary

In the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response prevention therapy (ERP) to improve treatment success in patients with OCD. This data will include tolerability information from therapists and patients with OCD, effect sizes on real world clinical outcomes for the combinatory treatment, and mechanistic data on brain changes associated with treatment.

Frequently Asked Questions

What is Paired tVNS With ERP in OCD?

Paired tVNS With ERP in OCD is a clinical trial registered under NCT05580614. Current status: RECRUITING.

What is the status of NCT05580614?

The current status of NCT05580614 (Paired tVNS With ERP in OCD) is: RECRUITING.

When did Paired tVNS With ERP in OCD start?

Paired tVNS With ERP in OCD started on 2022-06-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.